[Federal Register Volume 62, Number 198 (Tuesday, October 14, 1997)] [Notices] [Page 53338] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-27142] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By notice dated March 31, 1997, and published in the Federal Register on April 29, 1997, (62 FR 23268), Celgene Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacture of methylphenidate (1724) a basic class of controlled substance listed in Schedule II. DEA has considered the factors in Title 21, United States Code, Section 823(a), as well as information provided by other bulk manufacturers, and determined that the registration of Celgene Corporation to manufacturer methylphenidate is consistent with the public interest at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted. Dated: October 3, 1997. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administrator. [FR Doc. 97-27142 Filed 10-10-97; 8:45 am] BILLING CODE 4410-09-M